Select for export The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2023-07-26 Brain and Cognition Discovery Foundation ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.fitote.2023.105620 PubMed 37490982 Copy citation Copy BibTeX Unknown journal 2023-07-22 Jahanabadi S, Amiri S, Karkeh-Abadi M, Razmi A. Europe PMC Published psilocybinpsilocin DepressionMechanism of ActionReview Article Review Article More
Select for export Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psychres.2023.115349 PubMed 37523886 Copy citation Copy BibTeX Unknown journal 2023-07-22 Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR Europe PMC Published psilocybin DepressionMeta-AnalysisSystematic Review Meta-Analysis More
Select for export Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2023-07-18 Goodwin G, Marwood L, Mistry S, Nowakowska A, Simmons H, Tsai J Europe PMC Published psilocybin DepressionTreatment-Resistant Depression Other More
Select for export Psychedelics for depression: from neurobiology to treatment Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2023-07-18 Kuypers K. Europe PMC Published psilocybin DepressionMechanism of Action Other More
Select for export The therapeutic potential of psilocybin in depression resistant to psychotropic drugs No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2023-07-18 Ramírez González J, Fernández Márquez I, Ferreiro González S, Ruíz E. Europe PMC Published psilocybin Depression Other More
Select for export Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2023-07-18 Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C Europe PMC Published psilocybin DepressionNeuroplasticityNeurogenesis Systematic Review More
Select for export Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM. No abstract availability was recorded for this entry. Details DOI 10.1017/s0033291723002039 PubMed 37466289 Copy citation Copy BibTeX Unknown journal 2023-07-18 Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R Europe PMC Published psilocybin DepressionPersonality Change Other More
Select for export Psilocybin Therapy for Major Depressive Disorder: A Systematic Review Abstract available at the source but not redistributed here. Read at source. Details DOI 10.26685/urncst.489 Copy citation Copy BibTeX Undergraduate Research in Natural and Clinical Science and Technology Journal 2023-07-17 Venugopal Kaden L. Crossref Published psilocybin DepressionAnxietyWellbeing Systematic Review More
Select for export Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fnhum.2023.1200393 PubMed 37533588 Copy citation Copy BibTeX Frontiers in Human Neuroscience 2023-07-17 Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz OpenAlex Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Psilocybin-assisted psychotherapy for cancer-related anxiety and depression No abstract availability was recorded for this entry. Details DOI 10.1136/ijgc-2023-004659 PubMed 37463745 Copy citation Copy BibTeX International Journal of Gynecological Cancer 2023-07-17 Dan Yaniv, Lois M. Ramondetta, Lorenzo Cohen, Moran Amit OpenAlex Published psilocybin DepressionAnxietyCancer Patients Other More
Select for export Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-023-01648-7 PubMed 37443386 Copy citation Copy BibTeX Neuropsychopharmacology 2023-07-12 Guy M. Goodwin, Megan Croal, David Feifel, John R. Kelly, Lindsey Marwood, Sunil Mistry OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Australia’s approval of MDMA and psilocybin for PTSD and depression is premature, say critics No abstract availability was recorded for this entry. Details DOI 10.1136/bmj.p1599 PubMed 37433614 Copy citation Copy BibTeX BMJ 2023-07-10 Bianca Nogrady OpenAlex Published psilocybin DepressionPTSD Other More
Select for export Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/ztyxh Copy citation Copy BibTeX PsyArXiv 2023-07-05 Tetem J, Fischmann T, Möller TJ. PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD) Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2023-07-05 Cybin Therapeutics Inc. ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionReceptor Pharmacology Other More
Select for export Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2023-07-05 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231180276 PubMed 37403379 Copy citation Copy BibTeX Unknown journal 2023-07-03 Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ. Europe PMC Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Assessing potential of psilocybin for depressive disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/13543784.2023.2273493 PubMed 37869790 Copy citation Copy BibTeX Unknown journal 2023-06-30 Kozak Z, Johnson MW, Aaronson ST. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Clinical Trial More
Select for export Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjo.2023.535 PubMed 37489299 Copy citation Copy BibTeX BJPsych Open 2023-06-30 Muhammad Ishrat Husain, Daniel M. Blumberger, David Castle, Nicole Ledwos, Elise Fellows, Brett D. M. Jones OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Australia to prescribe MDMA and psilocybin for PTSD and depression in world first No abstract availability was recorded for this entry. Details DOI 10.1038/d41586-023-02093-8 PubMed 37386185 Copy citation Copy BibTeX Nature 2023-06-29 Rich Haridy OpenAlex Published psilocybin DepressionPTSDToxicity Other More
